Patents by Inventor Gail Phillips

Gail Phillips has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Anti-ErbB2 antibodies
    Publication number: 20080112957
    Abstract: Anti-ErbB2 antibodies are described which bind to an epitope in Domain 1 of ErbB2 and induce cell death via apoptosis. Various uses for these antibodies are also described.
    Type: Application
    Filed: October 31, 2007
    Publication date: May 15, 2008
    Applicants: Board of Regents, The University of Texas System, Genentech, Inc.
    Inventors: Brian Fendly, Gail Phillips, Richard Scheuermann, Jonathan Uhr
  • APO-2 ligand-anti-her-2 antibody synergism
    Publication number: 20070026001
    Abstract: Methods of using synergistically effective amounts of Apo-2 ligand and anti-Her-2 antibodies to enhance cell death via apoptosis are provided.
    Type: Application
    Filed: September 29, 2006
    Publication date: February 1, 2007
    Applicant: Genentech, Inc.
    Inventors: Avi Ashkenazi, Gail Phillips
  • Animal model of ligand activated HER2 expressing tumors
    Publication number: 20060212956
    Abstract: The invention concerns animal models of ligand activated HER2-expressing tumors. This model is useful for evaluating the efficacy of various therapeutic approaches for the treatment of such tumors.
    Type: Application
    Filed: March 13, 2006
    Publication date: September 21, 2006
    Inventors: Lisa Crocker, Sarajane Ross, Gail Phillips
  • Apo-2 ligand-anti-Her-2 antibody synergism
    Publication number: 20050244417
    Abstract: Methods of using synergistically effective amounts of Apo-2 ligand and anti-Her-2 antibodies to enhance cell death via apoptosis are provided.
    Type: Application
    Filed: June 15, 2005
    Publication date: November 3, 2005
    Inventors: Avi Ashkenazi, Gail Phillips